Alzheimer's disease

Alzheimer's disease (AD) or senile dementia of Alzheimer's type is a disorder of loss of mental functions resulting from brain tissue changes; the causes are yet to be fully elucidated (at least two genes predisposing to AD have been identified). The diagnostic characteristic of AD development of amyloid plaque in the brain. The typical visible symptom is progressive and chronic memory loss. Alzheimer's disease is also manifested in behavorial changes, which may even include sudden periods of defiance, abusive behavior, violence, etc. in people who have no previous history of such behavior (rarely, an affected person experiences euphoria). Thus, Alzheimer's disease presents a problem in patient management, as well. The symptoms of the disease as a distinct nosologic entity were first identified by Emil Kraepelin, and the characteristic neuropathology was first observed by Alois Alzheimer in 1906. In this sense, the disease was co-discovered by Kraepelin and Alzheimer, who worked in Kraepelin's laboratory. Because of the overwhelming importance Kraepelin attached to finding the neuropathological basis of psychiatric disorders, Kraepelin made the generous decision that the disease would bear Alzheimer's name (J. Psychiat. Res., 1997, Vol 31, No. 6, pp. 635-643).

Associated neuropathologic changes include loss of brain tissue cells (with a typical upward progression through memory centers such as the entorhinal cortex and the hippocampus) and collection of specific inclusions such as neurofibrillary ("tau") tangles and senile plaques. It is not yet certain whether these changes are primary (the cause of the disease) or secondary (the result of the disintegration of brain tissue), although the currently dominant hypothesis assigns cause to plaque. Whatever the mechanism, a strong epidemiological association has been shown between a diet high in fat and cholesterol and development and progress of the disease. In addition, animal feeding trials of high cholesterol and fat have demonstrated increased anatomical symptoms upon autopsied brains.

Alzheimer's disease is the most frequent reason for dementia in the elderly and affects almost half of all patients with dementia. There is no known definitive treatment, although there are drugs which reduce neurotransmitter degredation and delay memory loss associated with the disease. Non-steroidal anti-inflammatory drugs (including ibuprophen, acetominophen, and aspirin) seem to slow progress of the disease, according to clinical trials, but the mechanism is not understood.

The disease was thought to be uncommon, until the 1960s when it was realized that much of what had been regarded as the normal process of aging was actually the result of this disease. Alzheimer's is considered to be a major public health challenge since the average age of the industrialized world's population is increasing. Typically only 3% of persons aged 65 show signs of the disease while 50% of persons aged 85 have symptoms of Alzheimer's. However the proportion of persons with Alzheimer's begins to decrease after age 85 because of the increased mortality due to the disease, and relatively few people over the age of 100 have the disease.

There are ongoing tests of an Alzheimer's disease vaccine. Initial results in animals were promising. However when the first vaccines were used in humans, brain inflammation resulted and the trials were stopped. It is hoped that research will provide a better formulation and that in the future it can be of use in families with history of Alzheimer's Disease.

Unfortunately, a definitive diagnosis of Alzheimer's disease must await an autopsy, at present. However, many increasingly sophisticated diagnostic tests have been proposed (including: brain scans, behavioral tests and testing for genetic predisposition).

Psychological testing generally focuses on memory, attention, abstract thinking, the ability to name objects, and other cognitive functions. However, results of psychological tests do not easily distinguish between Alzheimers Disease and other types of dementia. Psychological testing can be helpful in establishing the presence of and severity of dementia. It can also be useful in distinguishing true dementia from temporary (and more treatable) cognitive impairment due to depression or psychosis, which has sometimes been termed pseudodementia.

See also: Familial Alzheimer disease

Famous Alzheimer's Sufferers



In the News

NSA Suits Head to San Francisco
Multiple lawsuits against telecommunications companies for allegedly helping the National Security Agency wiretap Americans will all move to the judge who didn't buy the government's "state secrets" argument. In 27B Stroke 6.

Shifting The World To 100 Percent Clean, Renewable Energy As Early As
Wind, water and solar energy resources are sufficiently available to provide all the world's energy. Converting to electricity and hydrogen powered by these sources would reduce world power demand by 30 percent, thereby avoiding 13,000 coal power plants. Materials and costs are not limitations to these conversions, but politics may be, say researchers who have mapped out a blueprint for powering the world.

Finally, a Sirius IPod Threat
Zing lets satellite subscribers connect wirelessly to music programming via Wi-Fi and Bluetooth. Apple and Microsoft take note. Commentary by Eliot Van Buskirk.

Exposure To Cats Increases Asthmatic Symptoms In People Without Specif
Researchers in the United Kingdom have found that increased exposure to cat allergen is associated with greater bronchial responsiveness (BR) in people with certain common allergies, even if they are not specifically allergic to cats. This suggests that reduced exposure to cats may be beneficial for allergic individuals, regardless of their specific allergies.

Single Molecule Based Electronic Components Modelled
Researchers have created the best method so far of assembling wire-like structures only a single molecule wide, a significant step in science's increasing attempts to reduce the circuitry size of electronic devices to the single molecule scale and provide smaller, faster, and more energy efficient electronics.

New View Of Cancer: 'Epigenetic' Changes Come Before Mutations
A Johns Hopkins researcher and colleagues in Sweden and at the Fred Hutchinson Cancer Research Center suggest that the traditional view of cancer as a group of diseases whose properties arise from a series of alterations within a cell's nuclear DNA may have to give way to a more complicated view. In the January issue of Nature Reviews Genetics, available online now, the scientists suggest that cancers instead begin with "epigenetic"alterations to stem cells.

[Ironic] LONDON: A jailed cocaine dealer is working as Santa Claus on
John Tams, who dons beard, boots and red suit to work in a cafe's Christmas grotto, said he wanted to give something back to the community...

Researchers Define Who We Are When We Work Together And Evolutionary O
Whether it is barn-raising or crafting a business plan, humans are among the few creatures that are able to work well cooperatively. According to an evolutionary psychologist at the University of Pennsylvania, our success at cooperation results from three distinct personality types.

In Wake Of Lyme Disease Vaccine For People, Mice May Be Next In Line F
As Americans queue up anxiously for flu shots, new research proposes a different sort of mass vaccination program to combat Lyme disease -- a vaccine drive for mice.

February 2: It's Not Just For Groundhogs Anymore
Groundhogs and other hibernators take a very sensible approach to winter: They slip into a state of suspended animation and let the worst of the cold weather pass. The cold prompts profound physiological changes in these animals, causing their normally fast metabolism to come almost to a stop during winter. With metabolism slowed to a crawl, the animal draws on its fat stores sparingly to make it through the winter.




MP3 Music Downloads

Preview songs, Download Free Music,Burn CDs at ITunes.com
iTunes_RGB_9mm

 


Google




InformationQuickFind.com - Find Information Fast

Links | Privacy Policy | News |